Search for: "TEVA PHARMACEUTICALS USA, INC." Results 1 - 20 of 405
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Apr 2019, 9:59 pm by Patent Docs
Teva Pharmaceuticals USA, Inc., the Federal Circuit reversed a decision by the U.S. [read post]
25 Nov 2015, 9:59 pm by Patent Docs
Teva Pharmaceuticals USA Inc., in a decision handed down earlier this month; the decision provides another example of the Court setting forth the contours of the scope of the... [read post]
29 Jul 2013, 9:26 pm by Patent Docs
This principle of patent law was reaffirmed by the Federal Circuit last week in Teva Pharmaceuticals USA, Inc. v. [read post]
10 Feb 2014, 7:01 pm by H. Scott Leviant
Teva Pharmaceuticals USA, Inc. was described as the end of the world by business interests when the Ninth Circuit held that attorneys could avoid CAFA removal by filing separate cases with fewer than 100 plaintiffs in each case to avoid the mass action provision in CAFA. [read post]
12 Oct 2010, 9:59 pm by Patent Docs
. ยง 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]
6 Aug 2014, 1:28 pm
Teva Pharmaceuticals USA, Inc. et al, the plaintiff alleged that metoclopramide, the generic name for Relgan, caused her to develop the neurologic condition known as tardive dyskinesia. [read post]
13 Aug 2020, 9:59 pm by Patent Docs
Teva Pharmaceuticals USA, Inc., affirmed a District Court's finding that the asserted claims to a pharmaceutical formulation were indefinite. [read post]
30 Aug 2020, 10:19 am by Ben Vernia
According to DOJ’s press release: The United States has filed a False Claims Act complaint against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]
1 Sep 2015, 9:59 pm by Patent Docs
Patent No. 7,772,209, owned by Lilly, would be infringed by the ANDA products for which Defendants Teva Parenteral Medicines, Inc.; Teva Pharmaceuticals USA, Inc.; APP Pharmaceuticals, LLC; Barr Laboratories, Inc.; and Pliva Hrvatska D.O.O. sought approval to market (opinion).... [read post]
23 Nov 2018, 8:03 pm by Patent Docs
Teva Pharmaceuticals USA Inc. case beginning at 4:00 pm (Eastern) on December 4, 2018 at the American University Washington College of Law in Washington, DC. [read post]
25 Jun 2017, 9:25 pm by Patent Docs
District Court for the District of Delaware issued a Memorandum Order that, inter alia, overruled objections by Defendants Glenmark Pharmaceuticals Inc., USA and Teva Pharmaceuticals USA, Inc. to a Report and Recommendation issued by Magistrate Judge Burke and adopted the Report. [read post]